Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The CXCR4-targeted theranostics era: a comprehensive review of a decade of progress (2015-2025).

Theranostics·2026
Same author

Characteristics and prognostic value of pre-treatment <sup>18</sup>F-FDG PET in neuroblastoma.

European journal of nuclear medicine and molecular imaging·2026
Same author

Comparative evaluation of PET quantitative methods for myocardial viability assessment in CAD patients and its prognostic value.

The international journal of cardiovascular imaging·2026
Same author

Integrated <sup>68</sup>Ga-PSMA PET/MRI models improve prostate cancer diagnosis and ISUP stratification, especially in the low-PSA cohort.

EJNMMI research·2026
Same author

<sup>18</sup>F-FDG PET/CT for Risk Stratification and Prognosis of Patients with Hypermetabolic Gastrointestinal Stromal Tumors.

Cancers·2026
Same author

First-in-Human Study of 68 Ga-FAP-75 PET Imaging of Cancer-associated Fibroblasts : Biodistribution, Radiation Dosimetry, and Tumor Delineation.

Clinical nuclear medicine·2025
Same journal

<sup>18</sup>F-Flurpiridaz PET in myocardial perfusion imaging: comparing effectiveness against traditional tracers.

American journal of nuclear medicine and molecular imaging·2026
Same journal

Positron emission tomography imaging of T-cell activity in cardiovascular disease and its emerging role in imaging adaptive immunity.

American journal of nuclear medicine and molecular imaging·2026
Same journal

Calibration and prediction of results after failed injection in SPECT renal dynamic imaging.

American journal of nuclear medicine and molecular imaging·2026
Same journal

Development and evaluation of a novel deuterated fluorine-18 PET tracer for MAO-B imaging.

American journal of nuclear medicine and molecular imaging·2026
Same journal

<sup>18</sup>F-NaF and <sup>18</sup>F-FDG PET/CT imaging of spinal instrumentation: case report and review of the literature.

American journal of nuclear medicine and molecular imaging·2026
Same journal

Bladder activity of different PSMA PET radioligands and impact of furosemide.

American journal of nuclear medicine and molecular imaging·2026
See all related articles

Related Experiment Video

Updated: Oct 7, 2025

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
10:33

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

520

Dimeric FAPI with potential for tumor theranostics.

Chunxia Qin1,2, Yangmeihui Song1,2, Weibo Cai3

  • 1Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430022, Hubei, China.

American Journal of Nuclear Medicine and Molecular Imaging
|January 10, 2022
PubMed
Summary
This summary is machine-generated.

New fibroblast activation protein inhibitors (FAPI) probes show enhanced tumor uptake and retention for improved nuclear imaging and potential cancer treatment. Dimeric structures offer a promising strategy for developing targeted radiotherapies.

Keywords:
Dimerendoradiotherapyfibroblast activation protein inhibitor (FAPI)imagingtumor

More Related Videos

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use
10:33

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

Published on: May 24, 2024

996
18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography
09:57

18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography

Published on: January 11, 2020

7.6K

Related Experiment Videos

Last Updated: Oct 7, 2025

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
10:33

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

520
An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use
10:33

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

Published on: May 24, 2024

996
18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography
09:57

18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography

Published on: January 11, 2020

7.6K

Area of Science:

  • Nuclear medicine
  • Radiochemistry
  • Oncology

Background:

  • Fibroblast activation protein inhibitors (FAPI) are crucial for tumor diagnosis and treatment.
  • Current FAPI probes require optimization for increased tumor uptake and retention.
  • Dimeric FAPI conjugates offer a potential strategy to enhance imaging and therapeutic efficacy.

Discussion:

  • Moon et al. developed two novel squaramide-coupled FAPI conjugates (DOTA.(SA.FAPi)2 and DOTAGA.(SA.FAPi)2).
  • These conjugates were labeled with Gallium-68 (68Ga) for positron emission tomography (PET) imaging.
  • The dimeric tracers demonstrated superior tumor accumulation and prolonged retention compared to existing probes.

Key Insights:

  • Dimeric FAPI structures significantly improve tumor targeting and retention in preclinical models.
  • The enhanced accumulation and retention of 68Ga-labeled dimeric FAPI tracers advance PET imaging capabilities for cancer.
  • This strategy holds promise for developing more effective FAPI-based radiotherapeutics.

Outlook:

  • Further research into dimeric FAPI conjugates could lead to improved cancer diagnostics and therapeutics.
  • The development of radiotherapeutic analogs based on FAPI inhibitors is a key future direction.
  • Optimized FAPI probes may reduce side effects and increase treatment efficacy in oncology.